Mustang Other Non Cash Items from 2010 to 2024

MBIO Stock  USD 0.19  0  2.11%   
Mustang Bio Other Non Cash Items yearly trend continues to be very stable with very little volatility. Other Non Cash Items is likely to drop to about 2.2 M. During the period from 2010 to 2024, Mustang Bio Other Non Cash Items quarterly data regression pattern had sample variance of 15.4 T and median of  7,862,000. View All Fundamentals
 
Other Non Cash Items  
First Reported
2015-12-31
Previous Quarter
-800 K
Current Value
29 K
Quarterly Volatility
2.6 M
 
Yuan Drop
 
Covid
Check Mustang Bio financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Mustang Bio's main balance sheet or income statement drivers, such as Interest Expense of 1.4 M, Selling General Administrative of 9 M or Total Revenue of 0.0, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 99.16. Mustang financial statements analysis is a perfect complement when working with Mustang Bio Valuation or Volatility modules.
  
Check out the analysis of Mustang Bio Correlation against competitors.
To learn how to invest in Mustang Stock, please use our How to Invest in Mustang Bio guide.

Latest Mustang Bio's Other Non Cash Items Growth Pattern

Below is the plot of the Other Non Cash Items of Mustang Bio over the last few years. It is Mustang Bio's Other Non Cash Items historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Mustang Bio's overall financial position and show how it may be relating to other accounts over time.
Other Non Cash Items10 Years Trend
Slightly volatile
   Other Non Cash Items   
       Timeline  

Mustang Other Non Cash Items Regression Statistics

Arithmetic Mean7,529,307
Geometric Mean6,491,589
Coefficient Of Variation52.07
Mean Deviation2,552,217
Median7,862,000
Standard Deviation3,920,800
Sample Variance15.4T
Range13.5M
R-Value(0.32)
Mean Square Error14.8T
R-Squared0.10
Significance0.24
Slope(283,285)
Total Sum of Squares215.2T

Mustang Other Non Cash Items History

20242.2 M
20232.3 M
20223.1 M
20217.7 M
202014.8 M
20198.6 M
20183.4 M

About Mustang Bio Financial Statements

Mustang Bio investors utilize fundamental indicators, such as Other Non Cash Items, to predict how Mustang Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Other Non Cash Items2.3 M2.2 M

Pair Trading with Mustang Bio

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Mustang Bio position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Mustang Bio will appreciate offsetting losses from the drop in the long position's value.

Moving together with Mustang Stock

  0.67VALN Valneva SE ADRPairCorr
  0.64ERNA Eterna TherapeuticsPairCorr

Moving against Mustang Stock

  0.58DYAI Dyadic InternationalPairCorr
  0.51ESPR Esperion TherapeuticsPairCorr
  0.47BMY Bristol Myers SquibbPairCorr
  0.36DNA Ginkgo Bioworks HoldingsPairCorr
The ability to find closely correlated positions to Mustang Bio could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Mustang Bio when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Mustang Bio - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Mustang Bio to buy it.
The correlation of Mustang Bio is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Mustang Bio moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Mustang Bio moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Mustang Bio can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Mustang Bio offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Mustang Bio's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Mustang Bio Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Mustang Bio Stock:
Check out the analysis of Mustang Bio Correlation against competitors.
To learn how to invest in Mustang Stock, please use our How to Invest in Mustang Bio guide.
You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Mustang Bio. If investors know Mustang will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Mustang Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.33)
Revenue Per Share
(0)
Return On Assets
(0.97)
Return On Equity
(11.91)
The market value of Mustang Bio is measured differently than its book value, which is the value of Mustang that is recorded on the company's balance sheet. Investors also form their own opinion of Mustang Bio's value that differs from its market value or its book value, called intrinsic value, which is Mustang Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Mustang Bio's market value can be influenced by many factors that don't directly affect Mustang Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Mustang Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Mustang Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Mustang Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.